Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Impact of Clinicopathological Features on Survival in Patients Treated With First-line Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma: A Meta-Analysis of Randomized Clinical TrialsEur Urol Focus 2021 Mar 10;[EPub Ahead of Print], A Rizzo, V Mollica, M Santoni, AD Ricci, M Rosellini, A Marchetti, R Montironi, A Ardizzoni, F Massari
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.